• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology Announces Unaudited First Quarter 2025 Financial Results

    5/16/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025.

    First Quarter 2025 Financial Highlights

    • Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.
    • Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.
    • U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.
    • Non-GAAP net income[1] was RMB251.1 million (US$34.6 million) in the first quarter of 2025, compared with RMB207.5 million in the same period of 2024.

    "We were pleased to deliver impressive results in the first quarter of 2025 amid a challenging macro environment," commented Ms. Ying (Kate) Wang, Co-founder, Chairperson of the Board of Directors, and Chief Executive Officer of RLX Technology. "E-vapor exports from China declined year over year in the first quarter due to bans on disposable products, excise taxes and an evolving regulatory environment, factors that will continue to impact the e-vapor industry as a whole throughout 2025. Stricter regulations are also driving shifts in market dynamics, with a transition to larger-volume e-liquid products emerging as a global trend, reflecting users' demand for convenient and cost-effective products. As a trusted brand with leading product R&D capabilities, robust inventory management systems, and a diverse global presence, RLX is well-positioned to navigate the ever-changing regulatory landscape and outperform the market, meeting the needs of adult smokers worldwide."

    Mr. Chao Lu, Chief Financial Officer of RLX Technology, added, "Our effective strategy and ongoing international expansion continued to support sustainable, profitable growth in the first quarter, driving a 46.5% year-over-year increase in net revenues to RMB808.3 million. Notably, our non-GAAP income from operations[1] also surged to RMB105.8 million thanks to our impactful cost optimization initiatives and operating leverage. While we expect regulatory and market challenges to persist, we remain confident in our ability to consistently propel high-quality business development and enhance shareholder value through strong strategic execution."

    First Quarter 2025 Financial Results

    Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024. The increase was primarily due to our international expansion.

    Gross profit was RMB231.0 million (US$31.8 million) in the first quarter of 2025, compared with RMB142.8 million in the same period of 2024.

    Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024. The increase was primarily due to a favorable change in the revenue mix and cost optimization initiatives.

    Operating expenses were RMB153.5 million (US$21.2 million) in the first quarter of 2025, compared with RMB194.4 million in the same period of 2024. The decrease was primarily due to the fluctuation of share-based compensation expenses. The changes in share-based compensation expenses were primarily due to the changes in the fair value of the share incentive awards that the Company granted to its employees in line with the fluctuations in the Company's share price.

    Selling expenses were RMB59.0 million (US$8.1 million) in the first quarter of 2025, compared with RMB52.9 million in the same period of 2024, primarily due to an increase in branding expenses, slightly offset by a decrease in salaries, welfare benefits and share-based compensation expenses.

    General and administrative expenses were RMB67.5 million (US$9.3 million) in the first quarter of 2025, compared with RMB110.0 million in the same period of 2024, primarily due to a decrease in share-based compensation expenses.

    Research and development expenses were RMB27.1 million (US$3.7 million) in the first quarter of 2025, compared with RMB31.5 million in the same period of 2024, primarily due to a decrease in share-based compensation expenses.

    U.S. GAAP income from operations was RMB77.4 million (US$10.7 million) in the first quarter of 2025, compared with loss from operations of RMB51.6 million in the same period of 2024.

    Non-GAAP income from operations was RMB105.8 million (US$14.6 million) in the first quarter of 2025, compared with RMB23.3 million in the same period of 2024.

    Income tax expense was RMB28.2 million (US$3.9 million) in the first quarter of 2025, compared with RMB16.3 million in the same period of 2024.

    U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.

    Non-GAAP net income was RMB251.1 million (US$34.6 million) in the first quarter of 2025, compared with RMB207.5 million in the same period of 2024.

    U.S. GAAP basic and diluted net income per American depositary share ("ADS") were RMB0.181 (US$0.025) and RMB0.170 (US$0.023), respectively, in the first quarter of 2025, compared with U.S. GAAP basic and diluted net income per ADS of RMB0.106 and RMB0.101, respectively, in the same period of 2024.

    Non-GAAP basic and diluted net income per ADS[2] were RMB0.204 (US$0.028) and RMB0.191(US$0.026), respectively, in the first quarter of 2025, compared with non-GAAP basic and diluted net income per ADS of RMB0.166 and RMB0.159, respectively, in the same period of 2024.

    Balance Sheet and Cash Flow

    As of March 31, 2025, the Company had cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, net, long-term bank deposits, net and long-term investment securities, net of RMB16,159.6 million (US$2,226.9 million), compared with RMB15,870.8 million as of December 31, 2024. In the first quarter of 2025, net cash generated from operating activities was RMB207.2 million (US$28.5 million).

    Conference Call

    The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025).

    Dial-in details for the earnings conference call are as follows:

    United States (toll-free):

    +1-888-317-6003

    International:

    +1-412-317-6061

    Hong Kong, China (toll-free):

    +800-963-976

    Hong Kong, China:

    +852-5808-1995

    Mainland China:

    400-120-6115

    Participant Code:

    9889875

    Participants should dial in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.

    Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.

    A replay of the conference call will be accessible approximately two hours after the conclusion of the call until May 23, 2025, by dialing the following telephone numbers:

    United States:

    +1-877-344-7529

    International:

    +1-412-317-0088

    Replay Access Code:

    6142221

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Non-GAAP Financial Measures

    The Company uses non-GAAP net income, non-GAAP operating profit and non-GAAP basic and diluted net income per ADS, each a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. Non-GAAP net income represents net income excluding share-based compensation expenses. Non-GAAP income from operations represents net operating profit excluding share-based compensation expenses. Non-GAAP basic and diluted net income per ADS is computed using non-GAAP net income attributable to RLX Technology Inc. and the same number of ADSs used in U.S. GAAP basic and diluted net income per ADS calculation.

    The Company presents these non-GAAP financial measures because they are used by the management to evaluate its operating performance and formulate business plans. The Company believes that they help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that are included in net income. The Company also believes that the use of the non-GAAP measures facilitates investors' assessment of its operating performance, as they could provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects, and allows for greater visibility with respect to key metrics used by the management in its financial and operational decision making.

    The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. They should not be considered in isolation or construed as an alternative to net income, basic and diluted net income per ADS or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review its historical non-GAAP financial measures to the most directly comparable U.S. GAAP measures. The non-GAAP financial measures here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. The Company encourages investors and others to review its financial information in its entirety and not rely on any single financial measure.

    For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliation of GAAP and non-GAAP Results" set forth at the end of this press release.

    Exchange Rate Information

    This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB7.2567 to US$1.00, the exchange rate on March 31, 2025, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" and similar statements. Among other things, quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward-looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; trends and competition in the global e-vapor market; changes in its revenues and certain cost or expense items; governmental policies, laws and regulations across various jurisdictions relating to the Company's industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is current as of the date of this press release, and the Company does not undertake any obligation to update such information, except as required under applicable law.

    For more information, please contact:

    In China:

    RLX Technology Inc.

    Head of Capital Markets

    Sam Tsang

    Email: [email protected]

    Piacente Financial Communications

    Jenny Cai

    Tel: +86-10-6508-0677

    Email: [email protected] 

    In the United States:

    Piacente Financial Communications

    Brandi Piacente

    Tel: +1-212-481-2050

    Email: [email protected] 

    [1] Non-GAAP net income and non-GAAP income from operations are non-GAAP financial measures. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    [2] Non-GAAP basic and diluted net income per ADS is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.



     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (All amounts in thousands)











    As of



    December 31,

    March 31,

    March 31,



    2024

    2025

    2025



    RMB

    RMB

    US$

    ASSETS







    Current assets:







    Cash and cash equivalents

    5,593,492

    4,711,236

    649,226

    Restricted cash

    50,867

    159,517

    21,982

    Short-term bank deposits, net

    2,179,886

    2,354,329

    324,435

    Receivables from online payment platforms

    4,722

    1,754

    242

    Short-term investments, net

    719,755

    1,097,481

    151,237

    Accounts and notes receivable, net

    78,484

    145,383

    20,034

    Inventories

    142,552

    116,495

    16,053

    Amounts due from related parties

    346,132

    184,608

    25,440

    Prepayments and other current assets, net

    185,091

    223,593

    30,812

    Total current assets

    9,300,981

    8,994,396

    1,239,461

    Non-current assets:







    Property, equipment and leasehold improvement, net

    50,787

    46,783

    6,447

    Intangible assets, net

    52,796

    50,290

    6,930

    Long-term investments, net

    8,000

    8,330

    1,148

    Deferred tax assets, net

    38,067

    38,067

    5,246

    Right-of-use assets, net

    24,110

    26,855

    3,701

    Long-term bank deposits, net

    727,448

    732,237

    100,905

    Long-term investment securities, net

    6,599,365

    7,104,813

    979,069

    Goodwill

    59,581

    59,728

    8,231

    Other non-current assets, net

    9,914

    11,979

    1,650

    Total non-current assets

    7,570,068

    8,079,082

    1,113,327

    Total assets

    16,871,049

    17,073,478

    2,352,788









    LIABILITIES AND SHAREHOLDERS' EQUITY







    Current liabilities:







    Accounts and notes payable

    458,538

    396,163

    54,593

    Contract liabilities

    10,610

    5,554

    765

    Salary and welfare benefits payable

    73,740

    64,829

    8,934

    Taxes payable

    126,154

    152,153

    20,967

    Short-term loan

    40,000

    60,000

    8,268

    Accrued expenses and other current liabilities

    108,816

    105,298

    14,510

    Amounts due to related parties

    27,401

    25,347

    3,493

    Dividend payable

    1,144

    -

    -

    Lease liabilities - current portion

    11,447

    10,303

    1,421

    Total current liabilities

    857,850

    819,647

    112,951









    Non-current liabilities:







    Deferred tax liabilities

    16,196

    16,226

    2,236

    Lease liabilities - non-current portion

    7,050

    13,259

    1,827

    Total non-current liabilities

    23,246

    29,485

    4,063

    Total liabilities

    881,096

    849,132

    117,014

















    Shareholders' Equity:







    Total RLX Technology Inc. shareholders' equity

    15,988,216

    16,221,973

    2,235,447

    Noncontrolling interests

    1,737

    2,373

    327

    Total shareholders' equity

    15,989,953

    16,224,346

    2,235,774









    Total liabilities and shareholders' equity

    16,871,049

    17,073,478

    2,352,788

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

    (All amounts in thousands, except for number of shares and per share data, or otherwise noted)



    For the three months ended



    March 31,

    December 31,

    March 31,

    March 31,



    2024

    2024

    2025

    2025



    RMB

    RMB

    RMB

    US$











    Net revenues

    551,623

    813,489

    808,300

    111,387

    Cost of revenues

    (327,610)

    (516,305)

    (477,526)

    (65,805)

    Excise tax on products

    (81,240)

    (77,278)

    (99,823)

    (13,756)

    Gross profit

    142,773

    219,906

    230,951

    31,826











    Operating expenses:









    Selling expenses

    (52,887)

    (45,369)

    (58,989)

    (8,129)

    General and administrative expenses

    (109,954)

    (153,710)

    (67,468)

    (9,297)

    Research and development expenses

    (31,540)

    (32,374)

    (27,055)

    (3,728)

    Total operating expenses

    (194,381)

    (231,453)

    (153,512)

    (21,154)











    (Loss)/income from operations

    (51,608)

    (11,547)

    77,439

    10,672











    Other income:









    Interest income, net

    158,858

    146,664

    135,953

    18,735

    Investment income

    12,776

    11,072

    8,386

    1,156

    Others, net

    28,943

    7,497

    29,143

    4,016

    Income before income tax

    148,969

    153,686

    250,921

    34,579

    Income tax expense

    (16,344)

    (26,303)

    (28,181)

    (3,884)

    Net income

    132,625

    127,383

    222,740

    30,695

    Less: net income attributable to noncontrolling interests

    717

    5,422

    700

    96

    Net income attributable to RLX Technology Inc.

    131,908

    121,961

    222,040

    30,599











    Other comprehensive income/(loss):









    Foreign currency translation adjustments

    12,706

    268,079

    (15,671)

    (2,160)

    Unrealized (loss)/income on long-term investment securities

    (13)

    (8,151)

    2,067

    285

    Total other comprehensive income/(loss)

    12,693

    259,928

    (13,604)

    (1,875)

    Total comprehensive income

    145,318

    387,311

    209,136

    28,820

    Less: total comprehensive income attributable to noncontrolling

    interests

    730

    5,442

    636

    88

    Total comprehensive income attributable to RLX Technology Inc.

    144,588

    381,869

    208,500

    28,732











    Net income per ordinary share/ADS 









    - Basic

    0.106

    0.100

    0.181

    0.025

    - Diluted

    0.101

    0.094

    0.170

    0.023











    Weighted average number of ordinary shares/ADSs









    - Basic

    1,249,317,641

    1,225,140,420

    1,226,330,482

    1,226,330,482

    - Diluted

    1,301,431,007

    1,291,925,422

    1,308,811,866

    1,308,811,866

     











    RLX TECHNOLOGY INC.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (All amounts in thousands, except for number of shares and per share data)





    For the three months ended



    March 31,

    December 31,

    March 31,

    March 31,



    2024

    2024

    2025

    2025



    RMB

    RMB

    RMB

    US$

    (Loss)/income from operations

    (51,608)

    (11,547)

    77,439

    10,672

    Add: share-based compensation expenses









             Selling expenses

    4,603

    13,020

    3,310

    456

             General and administrative expenses

    66,414

    103,894

    24,271

    3,345

             Research and development expenses

    3,881

    7,210

    745

    103

    Non-GAAP income from operations

    23,290

    112,577

    105,765

    14,576











    Net income

    132,625

    127,383

    222,740

    30,695

    Add: share-based compensation expenses









         Selling expenses

    4,603

    13,020

    3,310

    456

         General and administrative expenses

    66,414

    103,894

    24,271

    3,345

         Research and development expenses

    3,881

    7,210

    745

    103

    Non-GAAP net income

    207,523

    251,507

    251,066

    34,599











    Net income attributable to RLX Technology Inc.

    131,908

    121,961

    222,040

    30,599

    Add: share-based compensation expenses

    74,898

    124,124

    28,326

    3,904

    Non-GAAP net income attributable to RLX Technology Inc.

    206,806

    246,085

    250,366

    34,503











    Non-GAAP net income per ordinary share/ADS









    - Basic

    0.166

    0.201

    0.204

    0.028

    - Diluted

    0.159

    0.190

    0.191

    0.026

    Weighted average number of ordinary shares/ADSs









    - Basic

    1,249,317,641

    1,225,140,420

    1,226,330,482

    1,226,330,482

    - Diluted

    1,301,431,007

    1,291,925,422

    1,308,811,866

    1,308,811,866

























     

    RLX TECHNOLOGY INC.



    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



    (All amounts in thousands)















    For the three months ended





    March 31,

    December 31,

    March 31,

    March 31,





    2024

    2024

    2025

    2025





    RMB

    RMB

    RMB

    US$















    Net cash generated from operating activities

    4,020

    497,011

    207,165

    28,548



    Net cash generated from/(used in) investing activities

    420,665

    1,901,084

    (987,166)

    (136,035)



    Net cash (used in)/generated from financing activities

    (472,885)

    (130,366)

    14,435

    1,989



    Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash

    2,903

    62,865

    (8,040)

    (1,107)



    Net (decrease)/increase in cash and cash equivalents and restricted cash

    (45,297)

    2,330,594

    (773,606)

    (106,605)



    Cash, cash equivalents and restricted cash at the beginning of the period

    2,420,058

    3,313,765

    5,644,359

    777,813



    Cash, cash equivalents and restricted cash at the end of the period

    2,374,761

    5,644,359

    4,870,753

    671,208





















     

     

    Cision View original content:https://www.prnewswire.com/news-releases/rlx-technology-announces-unaudited-first-quarter-2025-financial-results-302457534.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RLX Technology Announces Unaudited First Quarter 2025 Financial Results

      SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

      5/16/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Files 2024 Annual Report on Form 20-F

      SHENZHEN, China, April 17, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC") on April 17, 2025. The annual report on Form 20-F can be accessed on the SEC's website at https://www.sec.gov and on the Company's investor relations website at https://ir.relxtech.com. The Company will provide a hard copy of its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. About RLX Technology Inc. RLX Techno

      4/17/25 8:00:00 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    SEC Filings

    See more
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      5/16/25 6:02:23 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by RLX Technology Inc.

      20-F - RLX Technology Inc. (0001828365) (Filer)

      4/17/25 4:01:47 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      3/14/25 6:10:16 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RLX Technology downgraded by Citigroup with a new price target

      Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

      3/17/25 7:42:34 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • UBS initiated coverage on RLX Technology with a new price target

      UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

      8/8/23 9:12:45 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/7/24 6:06:29 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/6/24 4:01:28 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/14/23 6:01:42 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Financials

    Live finance-specific insights

    See more
    • RLX Technology Announces Unaudited First Quarter 2025 Financial Results

      SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

      5/16/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

      SHENZHEN, China, March 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenues were RMB813.5 million (US$111.4 million) in the fourth quarter of 2024, compared with RMB520.5 million in the same period of 2023.Gross margin was 27.0% in the fourth quarter of 2024, compared with 23.7% in the same period of 2023.U.S. GAAP net income was RMB127.4 million (US$17.5 million) in the fourth quarter of 2024, compared with RMB216.0 million in the same period

      3/14/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care